Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI
暂无分享,去创建一个
J. van Lunzen | A. Lazzarin | J. Arribas | M. Nelson | W. Towner | E. Dejesus | M. Doroana | R. Swamy | J. Szwarcberg | C. Zurawski | Thai Nguyen | Damian McColl | K. Andreatta